- Home
- SSY vs GNPX Comparison
SSY vs GNPX Comparison
Compare SSY & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- GNPX
- Stock Information
- Founded
- SSY 1959
- GNPX 2009
- Country
- SSY United States
- GNPX United States
- Employees
- SSY N/A
- GNPX N/A
- Industry
- SSY Hospital/Nursing Management
- GNPX Biotechnology: Pharmaceutical Preparations
- Sector
- SSY Health Care
- GNPX Health Care
- Exchange
- SSY Nasdaq
- GNPX Nasdaq
- Market Cap
- SSY 6.2M
- GNPX 6.6M
- IPO Year
- SSY N/A
- GNPX 2018
- Fundamental
- Price
- SSY $0.88
- GNPX $0.23
- Analyst Decision
- SSY
- GNPX
- Analyst Count
- SSY 0
- GNPX 0
- Target Price
- SSY N/A
- GNPX N/A
- AVG Volume (30 Days)
- SSY 192.4K
- GNPX 3.6M
- Earning Date
- SSY 05-13-2025
- GNPX 08-08-2025
- Dividend Yield
- SSY N/A
- GNPX N/A
- EPS Growth
- SSY N/A
- GNPX N/A
- EPS
- SSY 0.25
- GNPX N/A
- Revenue
- SSY $31,094,000.00
- GNPX N/A
- Revenue This Year
- SSY N/A
- GNPX N/A
- Revenue Next Year
- SSY N/A
- GNPX N/A
- P/E Ratio
- SSY $3.57
- GNPX N/A
- Revenue Growth
- SSY N/A
- GNPX N/A
- 52 Week Low
- SSY $0.62
- GNPX $0.20
- 52 Week High
- SSY $1.91
- GNPX $3.97
- Technical
- Relative Strength Index (RSI)
- SSY 41.55
- GNPX 40.22
- Support Level
- SSY $0.95
- GNPX $0.22
- Resistance Level
- SSY $1.06
- GNPX $0.32
- Average True Range (ATR)
- SSY 0.09
- GNPX 0.03
- MACD
- SSY -0.01
- GNPX -0.01
- Stochastic Oscillator
- SSY 11.21
- GNPX 22.07
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.